GlassScriptPhysician profile
Allison Beasley
NPI 1457865487
$2,214.90
in general payments reported to CMS, 2019-2025
24 companies · $524 in 2025
The $524 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $235 · 2022: $124 · 2023: $423 · 2024: $908 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $351.60 | 2023-2025 | Lifevest |
| Cvrx, INC. | $217.18 | 2023-2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $185.02 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.00 | 2023-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $155.24 | 2023-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $138.33 | 2022-2023 | Ranger |
| Impulse Dynamics (USA) INC. | $132.55 | 2024 | Optimizer |
| Biohaven Pharmaceuticals, INC. | $122.55 | 2021 | |
| Ethicon US, LLC | $99.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $89.92 | 2023-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $85.53 | 2025 | Amvuttra |
| Philips North America LLC | $76.25 | 2024-2025 | Event, Mcot, (Ck4) Mcot |
| Kestra Medical Technology Services, INC. | $63.35 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $61.40 | 2023-2024 | Verquvo |
| Medicomp INC | $56.56 | 2024 | Telepatch Cardiac Monitor |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $31.39 | 2021-2023 | Hawkone |
| Actelion Pharmaceuticals US, INC. | $28.54 | 2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $24.37 | 2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $22.07 | 2024 | |
| Pfizer INC. | $21.50 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.05 | 2025 | |
| Novo Nordisk INC | $19.27 | 2024 | Wegovy |
| Amgen INC. | $17.42 | 2025 | Repatha |
| Davol INC. | $14.08 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.